Clinical Trial Update: Establishment of NAFLD Cohort and Development of Fibrosis Markers

View source ↗

Summary

The update describes establishment of a non-alcoholic fatty liver disease (NAFLD) cohort and development of biomarkers to assess liver fibrosis. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Seoul National University Boramae Hospital | Conditions: Fibrosis of Liver | Status: RECRUITING